Barry Thwaits brings 26 years of experience in the medical industry to his role as VP of International Sales at Inova Labs. Previously, Thwaits was employed at Philips Respironics where he worked in both the critical care market as well as the home health market. During his tenure at Philips Respironics, he held positions in sales management in North America as well as sales and marketing management in international markets. Prior to joining Inova Labs, Thwaits served as a business leader for a 50 million dollar business in his role as Markets Manager Latin America for Philips Respironics Home Health Solutions. Prior to that role, he managed a 450 million dollar budget as a VP of Sales in North America where he had responsibility for sales to strategic accounts in the Home Health Industry. He also has extensive experience working in Europe and the Middle East in both the Home Health Care and Critical Care Markets.
Thwaits holds a degree in Political Science from Arizona State University.
Ron Yarbrough joined Inova Labs as Vice President of RAQA in July of 2013. Prior to joining Inova Labs, Yarbrough served as Director of Regulatory Affairs and prior to that as Director of Quality Assurance for Zimmer Spine based in Minneapolis, MN. He has held a variety of positions with increasing responsibility at Zimmer Spine, Abbott Laboratories, Zimmer Orthopedics, Centerpulse, Sulzer, and Intermedics and worked in a variety of functions, including Product Development, Operations, Quality Assurance, and Regulatory Affairs management.
Yarbrough has over 15 years of extensive experience in the medical device industry dealing with a variety of Class I, II, and III products, as well as tissue banking. He has created and executed strategies to obtain predictable global product approvals and significantly improve product quality by implementing enhanced design controls and advanced production/process controls. Rising quickly from a top technical contributor to a position as divisional Director of Quality Assurance and then Regulatory Affairs, Yarbrough’s organizations led companies to establish world-class quality systems and successfully resolve chronic problems. Yarbrough is responsible for all global regulatory and quality activities and functions as the management representative for Inova Labs.
Yarbrough holds a Bachelor of Science degree in Industrial Technology from Texas State University.
Phil Martin has over 30 years of experience in the medical device industry. Prior to joining Inova Labs in 2011, Martin served as Vice President of Sales Interventional Cardiology for Boston Scientific from 2003 to 2010. He also served Boston Scientific as Director of Sales from 1994 to 2003. Prior to his experience with Boston Scientific, Martin spent over 10 years in Sales and Marketing at Johnson & Johnson.
Martin holds a Bachelor of Science degree in Business Management from Alfred University.
In January 2013, Dr. Dragan Nebrigic was appointed Chief Technology Officer at Inova Labs where he had held the position of Vice President of Product Development since February 2012. Dr. Nebrigic brings to Inova Labs more than 20 years of experience in medical devices and biotechnologies. He holds over 40 US and International Patents in the area of medical devices, consumer electronics and medical sensor technologies.
Prior to working at Inova Labs, Dr. Nebrigic served as Vice President of Research and Development with Thermage, as well as Vice President of Research and Development with Solta Medical. He also held the position of Senior Director of Global Advanced Technologies and Intellectual Property with Maxwell Technologies and served as the Executive Director of Engineering and Advanced Technologies with the American Technology Corporation and Molecular Reflections Corporation. During his tenure with Procter and Gamble from 1996 until 2000, Dr. Nebrigic spearheaded efforts related to novel portable energy sources as well as new consumer biosensor and portable medical devices applications. He also held an adjunct Professor position of Electrical Engineering with the University of Cincinnati.
Dr. Nebrigic holds a M.S. in Electrical and Computer Engineering and Technical Physics from the University of Belgrade Serbia and Ph.D. in Electrical and Computer Engineering from the University of Cincinnati.
John Rush has more than 28 years of experience in the medical device sector, and joined Inova Labs as Chief Executive Officer in 2011. Previously, Rush served as Chief Executive Officer of U.K. – based Lombard Medical Technologies PLC, a medical device company for the abdominal aortic aneurysm repair market, from 2009 to early 2011. Currently, Rush also serves as non-executive Chairman of the Lombard Medical Board of Directors. During his tenure at Lombard, the Company successfully navigated through an IDE PMA trial in the United States which led to FDA approval for it’s AAA stent graft in early 2013. Before joining Lombard, Rush was President and CEO of North American Scientific, Inc. (NASDAQ: NASM) where he re-organized the company and led an investor group initiative to take part of the company private. Rush also served as President and CEO of MicroTherapeutics, Inc. (NASDAQ:MTIX), an interventional neuroradiology company with operations in the United States and Europe. He orchestrated a successful sale of the company to ev3. Prior to MTIX, Rush spent 10 years with Scimed Life Systems/Boston Scientific in various management roles, including General Manager of Boston Scientific’s Asia Pacific business based in Singapore. Rush has extensive domestic and international experience, with a core sales and marketing background.